These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 1318398)
1. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. Perry ST; Flaherty MT; Kelley MJ; Clabough DL; Tronick SR; Coggins L; Whetter L; Lengel CR; Fuller F J Virol; 1992 Jul; 66(7):4085-97. PubMed ID: 1318398 [TBL] [Abstract][Full Text] [Related]
11. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo. Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113 [TBL] [Abstract][Full Text] [Related]
12. Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein. Yin X; Hu Z; Gu Q; Wu X; Zheng YH; Wei P; Wang X J Virol; 2014 Jan; 88(2):1259-70. PubMed ID: 24227834 [TBL] [Abstract][Full Text] [Related]
13. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. Cook RF; Leroux C; Cook SJ; Berger SL; Lichtenstein DL; Ghabrial NN; Montelaro RC; Issel CJ J Virol; 1998 Feb; 72(2):1383-93. PubMed ID: 9445039 [TBL] [Abstract][Full Text] [Related]
14. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain. Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667 [TBL] [Abstract][Full Text] [Related]
16. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism. Maury W; Thompson RJ; Jones Q; Bradley S; Denke T; Baccam P; Smazik M; Oaks JL J Virol; 2005 May; 79(9):5653-64. PubMed ID: 15827180 [TBL] [Abstract][Full Text] [Related]
17. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity. Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871 [TBL] [Abstract][Full Text] [Related]